Vertex to Acquire Crinetics Pharmaceuticals (CRNX) in $85 Per Share Cash Deal

On July 6, Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) and Vertex Pharmaceuticals announced that some companies person agreed to a definitive agreement, according to which Vertex volition get Crinetics Pharmaceuticals. The woody is priced astatine $85 a stock successful currency consideration, efficaciously valuing the acquisition astatine astir $10 cardinal oregon $8.8 cardinal aft accounting for the cash.

Romaset/Shutterstock.com

The Boards of some companies approved the transaction unanimously, with completion projected for the 3rd 4th of this year. Vertex plans to concern the acquisition done currency connected manus and $4.5 cardinal successful span financing from Bank of America and Morgan Stanley.

Following the announcement, Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) garnered a batch of attraction from analysts, who shared mixed opinions and revised their models based connected this acquisition. On July 7, Baird accrued its people terms connected the banal from $62 to $85, starring to an adjusted upside of much than 102%. The steadfast reiterated an Outperform standing connected the stock.

On July 8, Evercore ISI downgraded the banal from an Outperform standing to In Line. The terms people was besides lowered from $88 to $85, which inactive leaves charismatic upside potential.

Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) is engaged successful the improvement and selling of innovative treatments for uncommon endocrine diseases and endocrine-related tumors. The institution offers a scope of therapies that are presently successful antithetic stages of objective trials. These see Paltusotine, Atumelnant, CRN09682, oral GLP-1 and GIP nonpeptide.

While we admit the imaginable of CRNX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.